Enanta Pharmaceuticals, Inc. Insider Transactions
Enanta Pharmaceuticals, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Rottinghaus Scott T.
Chief Medical Officer |
Sell | 5,375 @ $17.08 | $91,805 | 21,717 | 07/15/2024 | 07/15/2024 | |
Rottinghaus Scott T.
Chief Medical Officer |
Sell | 2,271 @ $15.04 | $34,156 | 21,717 | 07/12/2024 | 07/15/2024 | |
Rottinghaus Scott T.
Chief Medical Officer |
Sell | 4,299 @ $15.07 | $64,786 | 23,988 | 07/11/2024 | 07/15/2024 | |
Kieffer Tara Lynn
Chief Product Strategy Officer |
Sell | 7,266 @ $12.33 | $89,590 | 32,341 | 06/17/2024 | 06/17/2024 | |
Vance Terry
Director |
Sell | 15,295 @ $9.12 | $139,490 | 5,800 | 12/13/2023 | 12/15/2023 | |
Luu Brendan
Sr. VP, Business Dev. |
Sell | 2,125 @ $9.63 | $20,464 | 36,736 | 12/05/2023 | 12/06/2023 | |
Kieffer Tara Lynn
Sr. VP, New Prod. Strat. & Dev |
Sell | 2,125 @ $9.63 | $20,464 | 37,260 | 12/05/2023 | 12/06/2023 | |
Gardiner Nathaniel S.
Sr. VP & General Counsel |
Sell | 2,412 @ $9.63 | $23,228 | 68,154 | 12/05/2023 | 12/06/2023 | |
Rottinghaus Scott T.
Sr. VP & CMO |
Sell | 534 @ $9.63 | $5,142 | 26,466 | 12/05/2023 | 12/06/2023 | |
Or Yat Sun
Sr. VP, R&D & CSO |
Sell | 2,412 @ $9.63 | $23,228 | 370,695 | 12/05/2023 | 12/06/2023 | |
MELLETT PAUL J
Sr. VP, Finance & Admin. & CFO |
Sell | 2,412 @ $9.63 | $23,228 | 93,549 | 12/05/2023 | 12/06/2023 | |
Luly Jay R.
CEO |
Sell | 7,230 @ $9.63 | $69,625 | 806,793 | 12/05/2023 | 12/06/2023 | |
MELLETT PAUL J
Treasurer and CFO |
Sell | 100 @ $43.96 | $4,396 | 107,896 | 03/15/2023 | 03/17/2023 | |
MELLETT PAUL J
Treasurer and CFO |
Sell | 10,340 @ $44.43 | $459,406 | 97,556 | 03/15/2023 | 03/17/2023 | |
Or Yat Sun
Sr. VP & CSO |
Sell | 269 @ $43.92 | $11,814 | 388,358 | 03/15/2023 | 03/17/2023 | |
Or Yat Sun
Sr. VP & CSO |
Sell | 13,656 @ $44.46 | $607,146 | 374,702 | 03/15/2023 | 03/17/2023 | |
Luly Jay R.
CEO |
Sell | 10,697 @ $44.81 | $479,333 | 837,025 | 03/13/2023 | 03/14/2023 | |
Luly Jay R.
CEO |
Sell | 15,649 @ $45.31 | $709,056 | 821,376 | 03/13/2023 | 03/14/2023 | |
Luly Jay R.
CEO |
Sell | 1,566 @ $46.13 | $72,240 | 819,810 | 03/13/2023 | 03/14/2023 | |
MELLETT PAUL J
Treasurer and CFO |
Sell | 4,200 @ $53.64 | $225,288 | 84,263 | 02/09/2023 | 02/13/2023 |
Enanta Pharmaceuticals, Inc. FAQ's
The list of insiders at Enanta Pharmaceuticals, Inc. includes Kieffer Tara Lynn, Rottinghaus Scott T..
Insiders have sold a total of 19,211 Enanta Pharmaceuticals, Inc. shares in the last 12 months for a total of 280,337 sold.
The following insiders have sold Enanta Pharmaceuticals, Inc. shares in the last 12 months: Kieffer Tara Lynn ($89,590), Rottinghaus Scott T. ($190,747),